|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號:C184170 |
| 產(chǎn)品名稱:L-Carnitine Orotate |
| 產(chǎn)品CAS:160468-17-7 |
| 規(guī)格含量:500mg |
| 產(chǎn)品價格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
C184170 |
| 名稱: |
L-Carnitine Orotate |
| 別名: |
(2R)-3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium-1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid Salt; (2R)-3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium-1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid Ion; (R)-3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium-1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid Ion; (R)- 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium-1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid; |
| CAS號: |
160468-17-7 |
| 參考CAS: |
Free Base: 44984-08-9 |
| 分子式: |
C?H??NO? •C?H?N?O? |
| 分子量: |
162.1115509 |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應用: |
L-Carnitine Orotate decreases seizure frequency in epileptic patients. Treats dermatosis such as ichthyosis and psoriasis. |
| 參考文獻 |
|
|
|
|